Related Experiment Video
Updated: Jun 28, 2026

Evaluation of Amino Acid Consumption in Cultured Bone Cells and Isolated Bone Shafts
Published on: April 13, 2022
Coffee consumption and bone mineral density in dialysis patients
Alicja E Grzegorzewska1, Monika Młot-Michalska
1Chair and Department of Nephrology, Transplantology and Internal Diseases, Karol Marcinkowski University of Medical Sciences, Poznań', Poland. alicja_grzegorzewska@yahoo.com
Insights
Coffee consumption may negatively impact bone mineral density (BMD) in dialysis patients. Daily coffee drinkers showed significantly lower BMD in the lumbar region compared to non-drinkers, suggesting a potential link to bone loss.
Area of Science:
- Nephrology
- Bone Metabolism
- Nutritional Science
Background:
- Bone mineral density (BMD) and fracture risk are critical concerns in dialysis patients.
- The impact of dietary factors, such as coffee consumption, on BMD in this population remains unclear.
Purpose of the Study:
- To investigate the association between regular coffee consumption and BMD in patients undergoing dialysis.
- To compare BMD and related parameters between coffee-drinking and non-coffee-drinking dialysis patients.
Main Methods:
- A comparative study of 30 dialysis patients, divided into coffee drinkers (Group I) and non-drinkers (Group II).
- Bone mineral density (BMD) was assessed at the femoral neck and L2-L4 lumbar region using dual-energy X-ray absorptiometry.
- Evaluated serum parathyroid hormone, calcium-phosphate balance, inflammation markers, body composition, and nutritional status.
Main Results:
- Coffee drinkers (Group I) exhibited significantly lower L2-L4 BMD, percent of peak BMD, percent of age norm, T-score, and Z-score compared to non-drinkers (Group II).
- Higher serum albumin concentration was observed in the coffee-drinking group.
- Statistical significance (p < 0.05) was noted for all key comparative findings.
Conclusions:
- Regular coffee consumption in dialysis patients is associated with reduced bone mineral density, particularly in the lumbar spine.
- Coffee intake may be a contributing factor to bone loss in patients with end-stage renal disease.
- Further research is warranted to elucidate the mechanisms behind this association.
Abstract:
The influence of ingested coffee on bone mineral density (BMD) and the related risk of pathologic fractures is controversial. We decided to check if dialysis patients drinking coffee may have a BMD different from that of non coffee drinkers. We studied 30 dialysis patients (26 on hemodialysis, 4 on peritoneal dialysis). Group I (n = 11, 5 women) included patients who regularly drank at least 1 cup of coffee daily [dialysis duration: 29.1 months (range: 8.7- 59.6 months); age: 56.0 +/- 14.6 years]. Group II (n = 19, 13 women) consisted of patients who said that they were nondrinkers of coffee [dialysis duration: 15.2 months (range: 6.3 - 45.4 months); age: 56.3 +/- 19.8 years]. We examined BMD in all subjects in two sites (femoral neck and L2 - L4 lumbar region) by dual-energy X-ray absorptiometry. Serum parathyroid hormone, calcium-phosphate balance parameters, blood pH, serum markers of inflammation, bioimpedance records of body composition, and markers of nutrition were simultaneously evaluated. Compared with group II, group I showed significantly lower L2 -L4 parameters: BMD (0.906 +/- 0.236 g/cm2 vs. 1.172 +/- 0.227 g/cm2, p = 0.005), percent of peak BMD (78.4% +/- 18.9% vs. 98.4% +/- 17.0%, p = 0.006), percent of age norm (82.7% +/- 18.2% vs. 105.9% +/- 17.7% p = 0.002), T-score [-2.07 (range: -3.95 to 2.02) vs. -0.51 (range: -2.29 to 4.07), p = 0.020], and Z-score [-1.25 (range: -4.41 to 1.90) vs. 0.26 (range: -1.48 to 4.49), p = 0.006]. Serum albumin concentration was higher in group I [4.0 g/dL (range: 3.1 - 4.3 g/dL) vs. 3.3 g/dL (range: 2.9 - 4.4 g/dL), p = 0.020]. Our results suggest that regular coffee consumption may contribute to BMD loss in dialysis patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hemodialysis III: Nursing Management
What is the Skeletal System?
